In EUR m
|
Q1 2022
|
Q1 2021
|
|
|
|
Revenue
|
385.0
|
311.9
|
EBITDA (adjusted)
|
94.6
|
73.5
|
Exceptional items
|
-3.3
|
-2.4
|
EBITDA
|
91.3
|
71.0
|
Amortization, depreciation and impairment losses
|
-70.8
|
-75.8
|
thereof attributable to purchase price allocations and impairment losses
|
-6.9
|
-10.5
|
EBIT
|
20.5
|
-4.8
|
Net finance income/costs
|
-6.0
|
-7.4
|
EBT
|
14.4
|
-12.2
|
Taxes
|
-3.3
|
2.7
|
Consolidated profit or loss for the period
|
11.1
|
-9.5
|
Adjusted consolidated profit or loss for the period
|
19.0
|
1.0
|
|
|
|
Free cash flow (before M&A transactions)
|
-2.2
|
13.0
|
Net debt (Mar. 31 / Dec 31.)
|
653.2
|
612.3
|